Warby Parker (WRBY) Stock Forecast & Price Target

Compare

298 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

WRBY Analyst Ratings

Strong Buy

6 Buy

1 Hold

0 Sell

Based on 7 analysts giving stock ratings to

Warby

Parker

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

WRBY Stock 12 Month Forecast

Average Price Target

$31.00

▲(30.75% Upside)

Based on 7 Wall Street analysts offering 12 month price targets for Warby Parker in the last 3 months. The average price target is $31.00 with a high forecast of $35.00 and a low forecast of $25.00. The average price target represents a 30.75% change from the last price of $23.71.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"15":"$15","36":"$36","20.25":"$20.3","25.5":"$25.5","30.75":"$30.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":35,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$35.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":31,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$31.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":25,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$25.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[15,20.25,25.5,30.75,36],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"May<br/>2025","6":"Aug<br/>2025","9":"Nov<br/>2025","12":"Feb<br/>2026","25":"Feb<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,26.03,26.720000000000002,27.41,28.1,28.79,29.48,30.17,30.86,31.55,32.24,32.93,33.620000000000005,34.31,{"y":35,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,26.03,26.412307692307692,26.794615384615387,27.176923076923078,27.55923076923077,27.941538461538464,28.323846153846155,28.706153846153846,29.088461538461537,29.470769230769232,29.853076923076923,30.235384615384618,30.61769230769231,{"y":31,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,26.03,25.950769230769232,25.871538461538464,25.792307692307695,25.713076923076922,25.633846153846154,25.554615384615385,25.475384615384616,25.396153846153847,25.31692307692308,25.237692307692306,25.158461538461538,25.07923076923077,{"y":25,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":27.71,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":24.73,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.44,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.48,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.48,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.78,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.6,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25.55,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":27.13,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.59,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 29, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.79,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 39, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.79,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 28, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":26.03,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$35.00

Average Price Target$31.00

Lowest Price Target$25.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Joe Feldman

Telsey Advisory

$32

Buy

34.96%

Upside

Reiterated

02/20/26

Analysts Offer Insights on Healthcare Companies: Insulet (NASDAQ: PODD), Charles River Labs (NYSE: CRL) and Warby Parker (NYSE: WRBY)

Anna Andreeva

Piper Sandler

$32

Buy

34.96%

Upside

Reiterated

02/20/26

Piper Sandler Remains a Buy on Warby Parker (WRBY)

Janine Stichter

BTIG

$32

Buy

34.96%

Upside

Reiterated

02/19/26

BTIG Sticks to Its Buy Rating for Warby Parker (WRBY)

Peter McGoldrick

Stifel Nicolaus

$25

Hold

5.44%

Upside

Reiterated

01/27/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Pennant Group (NASDAQ: PNTG), Regeneron (NASDAQ: REGN) and Warby Parker (NYSE: WRBY)

Mark Altschwager

Robert W. Baird

$27→$35

Buy

47.62%

Upside

Reiterated

12/17/25

Robert W. Baird Sticks to Its Buy Rating for Warby Parker (WRBY)

Dylan Carden

William Blair

Buy

―

Reiterated

12/11/25

Warby Parker's Strategic Partnership with Google Signals Promising Long-Term Growth

Andrew Boone

Citizens JMP

$30

Buy

26.53%

Upside

Upgraded

12/10/25

Warby Parker upgraded to Outperform from Market Perform at CitizensWarby Parker upgraded to Outperform from Market Perform at Citizens

Mark Carden

UBS

$23→$20

Hold

-15.65%

Downside

Reiterated

11/07/25

Warby Parker price target lowered to $20 from $23 at UBSWarby Parker price target lowered to $20 from $23 at UBS

Oliver Chen

TD Cowen

$28→$20

Buy

-15.65%

Downside

Reiterated

11/07/25

Warby Parker's Strategic Growth and Operational Efficiency Drive Buy Rating

Alexandra Straton

Morgan Stanley

$20→$19

Hold

-19.87%

Downside

Reiterated

11/07/25

Warby Parker price target lowered to $19 from $20 at Morgan StanleyWarby Parker price target lowered to $19 from $20 at Morgan Stanley

Brooke Roach

Goldman Sachs

$31→$27

Buy

13.88%

Upside

Reiterated

11/07/25

Goldman Sachs Keeps Their Buy Rating on Warby Parker (WRBY)

Matt Koranda

Roth MKM

$18

Hold

-24.08%

Downside

Reiterated

11/07/25

Roth MKM Keeps Their Hold Rating on Warby Parker (WRBY)

Mark Mahaney

Evercore ISI

$28

Hold

18.09%

Upside

Reiterated

09/08/25

Evercore ISI Reaffirms Their Hold Rating on Warby Parker (WRBY)

Paul Lejuez

Citi

$22→$24

Hold

1.22%

Upside

Reiterated

08/11/25

Warby Parker (WRBY) Gets a Hold from Citi

Anthony Chukumba

Loop Capital Markets

$27→$30

Buy

26.53%

Upside

Reiterated

08/07/25

Loop Capital Markets Reaffirms Their Buy Rating on Warby Parker (WRBY)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Joe Feldman

Telsey Advisory

$32

Buy

34.96%

Upside

Reiterated

02/20/26

Analysts Offer Insights on Healthcare Companies: Insulet (NASDAQ: PODD), Charles River Labs (NYSE: CRL) and Warby Parker (NYSE: WRBY)

Anna Andreeva

Piper Sandler

$32

Buy

34.96%

Upside

Reiterated

02/20/26

Piper Sandler Remains a Buy on Warby Parker (WRBY)

Janine Stichter

BTIG

$32

Buy

34.96%

Upside

Reiterated

02/19/26

BTIG Sticks to Its Buy Rating for Warby Parker (WRBY)

Peter McGoldrick

Stifel Nicolaus

$25

Hold

5.44%

Upside

Reiterated

01/27/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Pennant Group (NASDAQ: PNTG), Regeneron (NASDAQ: REGN) and Warby Parker (NYSE: WRBY)

Mark Altschwager

Robert W. Baird

$27→$35

Buy

47.62%

Upside

Reiterated

12/17/25

Robert W. Baird Sticks to Its Buy Rating for Warby Parker (WRBY)

Dylan Carden

William Blair

Buy

―

Reiterated

12/11/25

Warby Parker's Strategic Partnership with Google Signals Promising Long-Term Growth

Andrew Boone

Citizens JMP

$30

Buy

26.53%

Upside

Upgraded

12/10/25

Warby Parker upgraded to Outperform from Market Perform at CitizensWarby Parker upgraded to Outperform from Market Perform at Citizens

Mark Carden

UBS

$23→$20

Hold

-15.65%

Downside

Reiterated

11/07/25

Warby Parker price target lowered to $20 from $23 at UBSWarby Parker price target lowered to $20 from $23 at UBS

Oliver Chen

TD Cowen

$28→$20

Buy

-15.65%

Downside

Reiterated

11/07/25

Warby Parker's Strategic Growth and Operational Efficiency Drive Buy Rating

Alexandra Straton

Morgan Stanley

$20→$19

Hold

-19.87%

Downside

Reiterated

11/07/25

Warby Parker price target lowered to $19 from $20 at Morgan StanleyWarby Parker price target lowered to $19 from $20 at Morgan Stanley

Brooke Roach

Goldman Sachs

$31→$27

Buy

13.88%

Upside

Reiterated

11/07/25

Goldman Sachs Keeps Their Buy Rating on Warby Parker (WRBY)

Matt Koranda

Roth MKM

$18

Hold

-24.08%

Downside

Reiterated

11/07/25

Roth MKM Keeps Their Hold Rating on Warby Parker (WRBY)

Mark Mahaney

Evercore ISI

$28

Hold

18.09%

Upside

Reiterated

09/08/25

Evercore ISI Reaffirms Their Hold Rating on Warby Parker (WRBY)

Paul Lejuez

Citi

$22→$24

Hold

1.22%

Upside

Reiterated

08/11/25

Warby Parker (WRBY) Gets a Hold from Citi

Anthony Chukumba

Loop Capital Markets

$27→$30

Buy

26.53%

Upside

Reiterated

08/07/25

Loop Capital Markets Reaffirms Their Buy Rating on Warby Parker (WRBY)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Warby Parker

3 Months

xxx

Success Rate

7/12 ratings generated profit

Average Return

+13.41%

reiterated a xxx

rating 3 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 58.33% of your transactions generating a profit, with an average return of +13.41% per trade.

1 Year

Janine StichterBTIG

Success Rate

10/12 ratings generated profit

Average Return

+24.89%

reiterated a buy rating 3 days ago

Copying Janine Stichter's trades and holding each position for 1 Year would result in 83.33% of your transactions generating a profit, with an average return of +24.89% per trade.

2 Years

xxx

Success Rate

10/12 ratings generated profit

Average Return

+33.51%

reiterated a xxx

rating 3 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 83.33% of your transactions generating a profit, with an average return of +33.51% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

WRBY Analyst Recommendation Trends

Rating

Oct 25

Nov 25

Dec 25

Jan 26

Feb 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, WRBY has received 14 Buy Ratings, 12 Hold Ratings, and 0 Sell Ratings. WRBY average Analyst price target in the past 3 months is 31.00.

Each month's total comprises the sum of three months' worth of ratings.

WRBY Financial Forecast

WRBY Earnings Forecast

Next quarter’s earnings estimate for WRBY is $0.05 with a range of $0.02 to $0.08. The previous quarter’s EPS was $0.12. WRBY beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year WRBY has Performed in-line its overall industry.

WRBY Sales Forecast

Next quarter’s sales forecast for WRBY is $213.03M with a range of $210.20M to $216.13M. The previous quarter’s sales results were $221.68M. WRBY beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year WRBY has Performed in-line its overall industry.

WRBY Stock Forecast FAQ

What is WRBY’s average 12-month price target, according to analysts?

Based on analyst ratings, Warby Parker’s 12-month average price target is 31.00.

What is WRBY’s upside potential, based on the analysts’ average price target?

Warby Parker has 30.75% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is WRBY a Buy, Sell or Hold?

Warby Parker has a consensus rating of Strong Buy which is based on 6 buy ratings, 1 hold ratings and 0 sell ratings.

What is Warby Parker’s price target?

The average price target for Warby Parker is 31.00. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $35.00 ,the lowest forecast is $25.00. The average price target represents 30.75% Increase from the current price of $23.71.

What do analysts say about Warby Parker?

Warby Parker’s analyst rating consensus is a Strong Buy. This is based on the ratings of 7 Wall Streets Analysts.

How can I buy shares of WRBY?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Warby Parker (WRBY) Stock Forecast & Price Target

WRBY Analyst Ratings

WRBY Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Warby Parker

WRBY Analyst Recommendation Trends

WRBY Financial Forecast

WRBY Earnings Forecast

WRBY Sales Forecast

WRBY Stock Forecast FAQ

Detailed List of Analyst Forecasts